About Us
Led by a team of industry leaders, scientists and clinicians with deep NLRP3, drug development and commercial expertise, Rezera aims to eliminate chronic inflammation as a driver of cardiovascular and neurologic disease.
We believe that NLRP3 blockade can significantly reduce the impact of chronic inflammation on cardiovascular and neurologic disease, while preserving the natural ability to fight infections.
Cardiovascular and neurologic diseases impact the lives of over a billion people; we are determined to change that.
